Devices descending from K163563
1 later device reach VITEK 2 AST-GN Gentamicin (<=1 – >=16 µg/mL) through their predicates, nearest generation first.
| Generation | Number | Device | Applicant | Decided | Own descendants | Recalls |
|---|---|---|---|---|---|---|
| +1 | K223478 | VITEK® 2 AST-Gram Negative Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin… | bioMerieux, Inc. | 2023 | 0 | — |